Story perspectives

Study Uncovers Misleading Claims in New Zealand's Health Spending

9/12/2025

Summary

Health Spending Critique

A study from Auckland University criticizes New Zealand's health spending claims as "misleading" due to outdated data and GST inclusion.
The Congressional Budget Office (CBO) highlights that the 340B drug discount program has significantly increased costs, mainly from hospitals acquiring outpatient clinics.
Off-site outpatient clinics in the 340B program grew from 6,100 to 27,700 between 2013 and 2021, reflecting hospital consolidation.
Healthcare costs are expected to rise by 9% in 2026, driven by high prices for cancer drugs and weight loss treatments.
Hospital groups support the 340B program, emphasizing its role in aiding safety-net providers amid rising healthcare costs.

Summary

Medicaid Investigation Unfolds

California's Medicaid program is under investigation for potential overbilling of at least $500 million related to services for undocumented immigrants.
Budget cuts from the Trump administration threaten state health services, leading to the cancellation of the crucial Operation Border Health clinic.
Federal reimbursement rates for emergency services to undocumented immigrants will significantly decrease, affecting state budgets and healthcare access.
Hawaii and Delaware are responding to funding cuts, with Hawaii dedicating $50 million to support impacted nonprofits.
The Congressional Budget Office estimates that over 7.5 million individuals may lose Medicaid coverage due to new restrictions.

1 of 2

Health Spending Critique

A study from Auckland University criticizes New Zealand's health spending claims as "misleading" due to outdated data and GST inclusion.
The Congressional Budget Office (CBO) highlights that the 340B drug discount program has significantly increased costs, mainly from hospitals acquiring outpatient clinics.
Off-site outpatient clinics in the 340B program grew from 6,100 to 27,700 between 2013 and 2021, reflecting hospital consolidation.
Healthcare costs are expected to rise by 9% in 2026, driven by high prices for cancer drugs and weight loss treatments.
Hospital groups support the 340B program, emphasizing its role in aiding safety-net providers amid rising healthcare costs.

1 / 2